Mechanisms of Loss of Response to Adalimumab in Crohn's Disease

被引：0
|
作者：
Wolf, Douglas C.
Hauenstein, Scott
Lockton, Steven
Singh, Sharat
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S775 / S775
页数：1
相关论文
共 50 条
  • [31] Genetic prediction profile for adalimumab response in Slovenian Crohn's disease patients
    Gorenjak, Mario
    Repnik, Katja
    Jezernik, Gregor
    Jurgec, Stasa
    Skok, Pavel
    Potocnik, Uros
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (10): : 1218 - 1225
  • [32] Long-Term Durability of Response to Adalimumab Treatment in Crohn's Disease
    Chaparro, Maria
    Panes, Julian
    Garcia, V.
    Merino, Olga
    Nos, Pilar
    Domenech, Eugeni
    Penalva, Mireia
    Garcia-Planella, Esther
    Esteve, Maria
    Hinojosa, Joaquin
    Andreu, Montserrat
    Munoz, Fernando
    Gutierrez, Ana
    Mendoza, Juan L.
    Barrio, Jesus
    Barreiro, Manuel
    Vera, Isabel
    Vilar, Pere
    Cabriada, Jose Luis
    Montoro, Miguel A.
    Mante, Xavier Aldeguer
    Saro, Cristina
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2010, 138 (05) : S689 - S689
  • [33] Adalimumab for Cutaneous Metastatic Crohn's Disease
    Cury, Didia Bismara
    Moss, Alan C.
    Elias, Geraldo
    Nakao, Alexandre
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (05) : 723 - 724
  • [34] Adalimumab: the efficacy and safety in Crohn's disease
    Foster, R.
    Ambikaipaker, V.
    Radvan, G.
    Lawrence, O.
    Daley, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A87 - A87
  • [35] Adalimumab for Crohn's disease after an abscess
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (04):
  • [36] Adalimumab for maintenance of remission in Crohn's disease
    Townsend, Cassandra M.
    Nguyen, Tran M.
    Cepek, Jeremy
    Abbass, Mohamad
    Parker, Claire E.
    MacDonald, John K.
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (05):
  • [37] Ustekinumab vs adalimumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (09): : 793 - 793
  • [38] Commentary: infliximab or adalimumab in Crohn's disease?
    Sprakes, M. B.
    Hamlin, P. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (04) : 398 - 398
  • [39] Adalimumab for the treatment of pediatric Crohn's disease
    Nuti, Federica
    Fiorino, Gionata
    Danese, Silvio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (09) : 963 - 972
  • [40] Safety of adalimumab in patients with Crohn's disease
    Reactions Weekly, 2018, 1708 (1) : 13 - 13
12345